Jeffrey D. Janus, Chief Executive Officer
Jeffrey D. Janus is Chief Executive Officer of ESI BIO. Mr. Janus previously served as the CEO and founder of Lifeline Cell Technology, LLC, now a subsidiary of International Stem Cell, Inc., and was a member of the founding team that created Clonetics Corporation and the Clonetics brand of primary human cell systems, now owned by Lonza. In addition to his extensive experience in developing and selling cell-based products to the research market, Mr. Janus has led teams of scientists both internally and through external domestic and international collaborations with major academic institutions to conduct stem cell research. Mr. Janus has a Master’s Degree in Business Administration from California State University, San Diego and a Bachelor Degree in Biochemistry from the University of California at Davis. He is a published author of breakthrough papers in the development of parthenogenetic stem cells and cell-based assays.
Connect with Jeffrey in Social Media:LinkedIn Profile
Robert W. Peabody, Senior VP, COO, CFO
Robert W. Peabody is Senior Vice-President, Chief Operating Officer, and Chief Financial Officer of ESI BIO and BioTime, Inc. Mr. Peabody has served as Senior Vice President and Chief Operating Officer since 2007, and also served on an interim basis as Chief Financial Officer from September 2010 until October 2011 before reassuming the role in May 2013. Prior to joining BioTime, Mr. Peabody served as a Vice President of Advanced Cell Technology, Inc. and also served on their board of directors from 1998 to 2006. Mr. Peabody also spent 14 years as a Regional Controller for Ecolab, Inc., a Fortune 500 specialty chemical manufacturer and service company. He has also been an audit manager for Ernst and Young where he was a Certified Public Accountant on the audit staff serving the firm’s clients whose shares are publicly traded. Mr. Peabody received a Bachelor Degree in Business Administration from the University of Michigan.
Hal Sternberg, Ph.D., VP of Research
Hal Sternberg, Ph.D. has been Vice President of Research since 1990 and is one of the co-founders of BioTime. Dr. Sternberg was a visiting scientist and research Associate at the University of California at Berkeley from 1985-1988, where he supervised a team of researchers studying Alzheimer's Disease. Dr. Sternberg received his Ph.D. from the University of Maryland in Biochemistry in 1982.
Michael D. West, Ph.D.
Michael D. West, Ph.D., Chief Executive Officer of BioTime, Inc, ESI BIO's parent company, has served on the Board of Directors since 2002. Dr. West served as Chief Executive Officer, President, and Chief Scientific Officer of Advanced Cell Technology, Inc., a company engaged in developing human stem cell technology for use in regenerative medicine. Dr. West also founded Geron Corporation of Menlo Park, California, and from 1990 to 1998 he was a Director and Vice-President, where he initiated and managed programs in telomerase diagnostics, oligonucleotide-based telomerase inhibition as anti-tumor therapy, and the cloning and use of telomerase in telomerase-mediated therapy wherein telomerase is utilized to immortalize human cells. From 1995 to 1998 he organized and managed the research between Geron and its academic collaborators James Thomson and John Gearhart that led to the first isolation of human embryonic stem and human embryonic germ cells. Dr. West received a B.S. Degree from Rensselaer Polytechnic Institute in 1976, an M.S. Degree in Biology from Andrews University in 1982, and a Ph.D. from Baylor College of Medicine in 1989 concentrating on the biology of cellular aging.
Connect with Dr. West:BioTime Website